Page last updated: 2024-08-24

sarafloxacin and difloxacin

sarafloxacin has been researched along with difloxacin in 43 studies

Research

Studies (43)

Timeframe	Studies, this research(%)	All Research%
pre-1990	26 (60.47)	18.7374
1990's	3 (6.98)	18.2507
2000's	9 (20.93)	29.6817
2010's	5 (11.63)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chu, DT; Claiborne, AK; Fernandes, PB; Maleczka, RE; Nordeen, CW; Pernet, AG; Pihuleac, E	1
Chen, S; Cui, S; McDermott, PF; Meng, J; Paulsen, I; White, DG; Zhao, S	1
Gozalbes, R; Pineda-Lucena, A	1
Pattyn, SR	1
Bauer, JF; Elrod, L; Fornnarino, JR; Heathcote, DE; Krogh, SK; Linton, CL; Norris, BJ; Quick, JE	1
Chandrasekar, PH; Sluchak, JA	1
Ayers, LW; Barry, AL; Gavan, TL; Gerlach, EH; Jones, RN; Thornsberry, C	1
Smith, SM	1
Barry, AL; Jones, RN; Thornsberry, C	1
Bailer, R; Chu, DT; Fernandes, PB; Hanson, CW; Stamm, JM; Vojtko, C	1
Liu, S; Meyer, RD	1
Fok, M; Gollapudi, SV; Gupta, S; Thadepalli, H; Vayuvegula, B	1
Michel, MF; Piot, P; Stolz, E; Tjiam, KH; van Klingeren, B; Wagenvoort, JH	1
Black, WA; Bowie, WR; Boyd, J; Chan, DG; Shaw, CE	1
Ballard, RC; Fehler, G; Koornhof, HJ; Liebowitz, LD; Saunders, J	1
Habiyaremye, I; Vandepitte, J; Verbist, L	1
Verbist, L	1
Dibb, WL; Digranes, A	1
Deforges, L; Duval, J; Le Van Thoi, J; Soussy, CJ	1
Ackerman, VP; Fernandes, CJ; Wilson, RD	1
Bodey, GP; Ho, DH; LeBlanc, B; Rolston, KV	2
King, A; Phillips, I	1
Bower, RR; Chu, DT; Fernandes, PB; Jarvis, KP; Ramer, NR; Shipkowitz, N	1
Chuah, SK; Gollapudi, SV; Thadepalli, H	1
Adams, KR; Mader, JT; Morrison, LT	1
Bansal, MB; Thadepalli, H	1
Donato, JB; Joseph, WS; LeFrock, JL; Smith, BR; Weber, SJ	1
Hirschhorn, L; Neu, HC	1
Eliopoulos, GM; Moellering, AE; Moellering, RC; Reiszner, E	1
Ellis, R; Niedzielska, J; Posyniak, A; Semeniuk, S; Zmudzki, J	1
Buckley, SA; Holtzapple, CK; Stanker, LH	1
Bailac, S; Barbosa, J; Barrón, D; Jiménez-Lozano, E	1
Darwish, AM; Freeman, DW; Schneider, MJ	1
Chen, X; Hua, H; Ji, C; Lin, X; Liu, Y; Tang, S; Yue, Z	1
Kusari, S; Lamshöft, M; Spiteller, M; Sukul, P; Zühlke, S	1
Kusari, S; Lamshöft, M; Prabhakaran, D; Spiteller, M	1
Bohoyo Gil, D; Guiberteau Cabanillas, A; Martínez Cañas, MA; Rodríguez Cáceres, MI	1
Lamshöft, M; Maheswari, MA; Prabhakaran, D; Spiteller, M; Sukul, P; Zühlke, S	1
Galeano Díaz, T; Guiberteau Cabanillas, A; Martínez Cañas, MA; Rodríguez Cáceres, MI	1
Anadón, A; Ares, I; Castellano, V; Gamboa, F; Martínez, M; Martínez, MA; Martínez-Larrañaga, MR; Ramos, E; Suárez, FH	1
Companyó, R; Guiteras, J; Jiménez, V	1
Albiol-Chiva, J; Carda-Broch, S; Esteve-Romero, J; Iborra-Millet, JJ; Peris-Vicente, J	1

Other Studies

43 other study(ies) available for sarafloxacin and difloxacin

Article	Year
Synthesis and structure-activity relationships of novel arylfluoroquinolone antibacterial agents. Journal of medicinal chemistry, 1985, Volume: 28, Issue:11 Topics: Acinetobacter; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Chemical Phenomena; Chemistry; Ciprofloxacin; Enterobacter; Escherichia coli; Female; Fluorine; Fluoroquinolones; Klebsiella pneumoniae; Mice; Norfloxacin; Pefloxacin; Piperazines; Pseudomonas aeruginosa; Quinolines; Staphylococcus; Streptococcus; Structure-Activity Relationship	1985
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:2 Topics: Animals; Anti-Infective Agents; DNA Topoisomerases; Drug Resistance, Bacterial; Fluoroquinolones; Gene Targeting; Genes, Bacterial; Mutation; Salmonella Infections, Animal; Salmonella typhimurium	2007
QSAR-based solubility model for drug-like compounds. Bioorganic & medicinal chemistry, 2010, Oct-01, Volume: 18, Issue:19 Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water	2010
Anti-Mycobacterium leprae activity of several quinolones studied in the mouse. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1991, Volume: 59, Issue:4 Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Fleroxacin; Fluoroquinolones; Leprosy; Mice; Mycobacterium leprae; Quinolones	1991
Determination of temafloxacin, sarafloxacin, and difloxacin in bulk drug and dosage forms by high-performance liquid chromatography. Pharmaceutical research, 1990, Volume: 7, Issue:11 Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Fluoroquinolones; Quinolones; Solubility; Spectrophotometry, Ultraviolet	1990
Newer agents against methicillin and/or gentamicin-resistant and -susceptible staphylococci. Chemotherapy, 1989, Volume: 35, Issue:5 Topics: Anti-Bacterial Agents; Ciprofloxacin; Daptomycin; Drug Resistance, Microbial; Fluoroquinolones; Gentamicins; Humans; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Peptides; Species Specificity; Staphylococcus aureus	1989
In vitro activity of the aryl-fluoroquinolones A-56619 and A-56620 and evaluation of disk susceptibility tests. European journal of clinical microbiology, 1986, Volume: 5, Issue:1 Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Microbial Sensitivity Tests; Norfloxacin; Piperazines; Quinolines; Staphylococcus; Streptococcus	1986
In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus. Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:2 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Methicillin; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Penicillin Resistance; Piperazines; Quinolines; Staphylococcus aureus	1986
In vitro evaluation of A-56619 and A-56620, two new quinolones. Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:1 Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Piperazines; Quinolines	1986
In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones. Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:2 Topics: Anti-Infective Agents; Aztreonam; Bacteria; Cefotaxime; Ciprofloxacin; Drug Combinations; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Gentamicins; Haemophilus influenzae; Half-Life; Humans; Imipenem; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin; Penicillins; Piperacillin; Piperazines; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus; Streptococcus; Thienamycins	1986
In vitro activity of aryl fluoroquinolones, Abbott 56619 and Abbott 56620, compared to ciprofloxacin, norfloxacin and beta-lactams versus multidrug-resistant Enterobacteriaceae and Pseudomonas aeruginosa. Chemotherapy, 1986, Volume: 32, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Microbial Sensitivity Tests; Norfloxacin; Pseudomonas aeruginosa	1986
Aryl-fluoroquinolone derivatives A-56619 (difloxacin) and A-56620 inhibit mitogen-induced human mononuclear cell proliferation. Antimicrobial agents and chemotherapy, 1986, Volume: 30, Issue:3 Topics: Anti-Infective Agents; Cells, Cultured; Ciprofloxacin; Fluoroquinolones; Humans; In Vitro Techniques; Interleukin-2; Lymphocyte Activation; Mitogens; Monocytes; Receptors, Immunologic; Receptors, Interleukin-2	1986
In vitro activity of the two new 4-quinolones A56619 and A56620 against Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum and Gardnerella vaginalis. European journal of clinical microbiology, 1986, Volume: 5, Issue:5 Topics: Anti-Bacterial Agents; Bacteria; Chlamydia trachomatis; Ciprofloxacin; Fluoroquinolones; Gardnerella vaginalis; Humans; Microbial Sensitivity Tests; Mycoplasma; Neisseria gonorrhoeae; Tetracycline; Ureaplasma	1986
In vitro activity of difloxacin hydrochloride (A-56619), A-56620, and cefixime (CL 284,635; FK 027) against selected genital pathogens. Antimicrobial agents and chemotherapy, 1986, Volume: 30, Issue:4 Topics: Anti-Bacterial Agents; Bacteria; Cefixime; Cefotaxime; Chlamydia trachomatis; Ciprofloxacin; Female; Fluoroquinolones; Gardnerella vaginalis; Genitalia; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae	1986
In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens. Antimicrobial agents and chemotherapy, 1986, Volume: 30, Issue:6 Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Ciprofloxacin; Female; Fluoroquinolones; Gardnerella vaginalis; Genitalia; Haemophilus; Haemophilus ducreyi; Humans; Male; Microbial Sensitivity Tests; Mycoplasma; Neisseria gonorrhoeae; Norfloxacin; Ofloxacin; Oxazines; Ureaplasma	1986
[Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria]. Pathologie-biologie, 1987, Volume: 35, Issue:5 Pt 2 Topics: Anti-Bacterial Agents; Campylobacter fetus; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Salmonella; Shigella; Vibrio cholerae; Yersinia enterocolitica	1987
Comparative in-vitro activity of Ro 23-6240, a new trifluorinated quinolone. The Journal of antimicrobial chemotherapy, 1987, Volume: 20, Issue:3 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Gram-Negative Bacteria; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines	1987
In vitro activities of A-56619 (difloxacin) and A-56620, two aryl fluoroquinolones. Chemotherapy, 1988, Volume: 34, Issue:4 Topics: Anti-Bacterial Agents; Ciprofloxacin; Culture Media; Fluoroquinolones; Gram-Negative Bacteria; Hydrogen-Ion Concentration; Microbial Sensitivity Tests	1988
[In vitro antibacterial activity of 2 new quinolones: A 56619 (difloxacin) and A 56620. Comparison with pefloxacin, ofloxacin and ciprofloxacin]. Pathologie-biologie, 1987, Volume: 35, Issue:5 Pt 2 Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Fluoroquinolones; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin	1987
In vitro activity of A-56619 and A-56620 against multi-resistant and routine clinical isolates. Chemotherapy, 1988, Volume: 34, Issue:3 Topics: Anti-Bacterial Agents; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Pseudomonas; Staphylococcus; Streptococcus	1988
In vitro evaluation of difloxacin (A-56619), A-56620, and other 4-quinolones against isolates from cancer patients. Chemotherapy, 1987, Volume: 33, Issue:6 Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Evaluation, Preclinical; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Neoplasms; Quinones; Sepsis	1987
The comparative in-vitro activity of eight newer quinolones and nalidixic acid. The Journal of antimicrobial chemotherapy, 1986, Volume: 18 Suppl D Topics: Acinetobacter; Aeromonas; Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pefloxacin; Quinolines	1986
In vitro evaluation of S-25930 and S-25932, two new quinolones, against aerobic gram-negative isolates from cancer patients. Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Enoxacin; Fluoroquinolones; Gram-Negative Bacteria; Humans; Naphthyridines; Neoplasms; Quinolizines	1987
In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones. Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:2 Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Fluoroquinolones; Half-Life; Immunosuppression Therapy; Klebsiella Infections; Mice; Norfloxacin; Piperazines; Proteus Infections; Pseudomonas Infections; Pyelonephritis; Quinolines; Salmonella Infections, Animal; Staphylococcal Infections; Streptococcal Infections	1986
Therapeutic evaluation of difloxacin (A-56619) and A-56620 for experimentally induced Bacteroides fragilis-associated intra-abdominal abscess. Antimicrobial agents and chemotherapy, 1986, Volume: 30, Issue:4 Topics: Abscess; Animals; Anti-Bacterial Agents; Ascitic Fluid; Bacteroides fragilis; Bacteroides Infections; Ciprofloxacin; Escherichia coli; Fluoroquinolones; Half-Life; Male; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains	1986
Comparative evaluation of A-56619, A-56620, and nafcillin in the treatment of experimental Staphylococcus aureus osteomyelitis. Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:2 Topics: Animals; Anti-Bacterial Agents; Bone and Bones; Ciprofloxacin; Fluoroquinolones; Nafcillin; Osteomyelitis; Rabbits; Random Allocation; Staphylococcal Infections; Staphylococcus aureus; Tissue Distribution	1987
Activity of difloxacin (A-56619) and A-56620 against clinical anaerobic bacteria in vitro. Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:4 Topics: Anti-Infective Agents; Bacteria, Anaerobic; Cefoxitin; Ciprofloxacin; Drug Synergism; Fluoroquinolones; Microbial Sensitivity Tests; Species Specificity	1987
In vitro activity of A-56619 and A56620, two new aryl-fluoroquinolone antimicrobial agents. Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:2 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Norfloxacin; Piperazines; Quinolines	1986
Factors influencing the in vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620. Antimicrobial agents and chemotherapy, 1986, Volume: 30, Issue:1 Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Magnesium; Piperazines; Quinolines	1986
In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620. Antimicrobial agents and chemotherapy, 1985, Volume: 28, Issue:4 Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Piperazines; Pseudomonas aeruginosa; Quinolines; Time Factors	1985
Determination of fluoroquinolone residues in animal tissues by liquid chromatography. Biomedical chromatography : BMC, 1999, Volume: 13, Issue:4 Topics: Animals; Anti-Infective Agents; Cattle; Chromatography, Liquid; Ciprofloxacin; Drug Residues; Fluoroquinolones; Kidney; Liver; Muscles; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Swine	1999
Determination of fluoroquinolones in serum using an on-line clean-up column coupled to high-performance immunoaffinity-reversed-phase liquid chromatography. Journal of chromatography. B, Biomedical sciences and applications, 2001, Apr-15, Volume: 754, Issue:1 Topics: Animals; Anti-Infective Agents; Cattle; Chromatography, Affinity; Chromatography, High Pressure Liquid; Ciprofloxacin; Enrofloxacin; Fluoroquinolones; Immunochemistry; Molecular Structure; Quinolones	2001
Determination of difloxacin and sarafloxacin in chicken muscle using solid-phase extraction and capillary electrophoresis. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2002, Feb-15, Volume: 767, Issue:2 Topics: Animals; Anti-Infective Agents; Chickens; Ciprofloxacin; Drug Residues; Electrophoresis, Capillary; Fluoroquinolones; Muscles; Reference Standards; Reproducibility of Results; Sensitivity and Specificity	2002
Simultaneous multiresidue determination of tetracyclines and fluoroquinolones in catfish muscle using high performance liquid chromatography with fluorescence detection. Analytica chimica acta, 2007, Mar-14, Volume: 586, Issue:1-2 Topics: Animals; Catfishes; Chlortetracycline; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Residues; Enrofloxacin; Fluoroquinolones; Muscles; Oxytetracycline; Spectrometry, Fluorescence; Tetracyclines	2007
[Determination of 16 quinolone residues in animal tissues using high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry]. Se pu = Chinese journal of chromatography, 2007, Volume: 25, Issue:4 Topics: Animals; Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Enrofloxacin; Fluoroquinolones; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization	2007
Metabolism and excretion kinetics of 14C-labeled and non-labeled difloxacin in pigs after oral administration, and antimicrobial activity of manure containing difloxacin and its metabolites. Environmental research, 2009, Volume: 109, Issue:3 Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Calibration; Carbon Radioisotopes; Ciprofloxacin; Environmental Pollutants; Male; Manure; Microbial Sensitivity Tests; Reference Standards; Swine	2009
In vitro residual anti-bacterial activity of difloxacin, sarafloxacin and their photoproducts after photolysis in water. Environmental pollution (Barking, Essex : 1987), 2009, Volume: 157, Issue:10 Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Residues; Photolysis; Water Pollutants, Chemical	2009
Quantification of danofloxacin and difloxacin in chicken tissues in the presence of sarafloxacin as interference. Journal of agricultural and food chemistry, 2009, Sep-09, Volume: 57, Issue:17 Topics: Animals; Anti-Bacterial Agents; Chickens; Ciprofloxacin; Fluoroquinolones; Food Contamination; Muscles; Reproducibility of Results; Spectrometry, Fluorescence	2009
Photolysis of difloxacin and sarafloxacin in aqueous systems. Chemosphere, 2009, Volume: 77, Issue:6 Topics: Anti-Bacterial Agents; Ciprofloxacin; Environmental Restoration and Remediation; Half-Life; Humic Substances; Hydrogen-Ion Concentration; Kinetics; Light; Photolysis; Water; Water Pollutants, Chemical	2009
Simultaneous determination of quinolones for veterinary use by high-performance liquid chromatography with electrochemical detection. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2010, Feb-01, Volume: 878, Issue:3-4 Topics: Animals; Calibration; Chickens; Chromatography, High Pressure Liquid; Ciprofloxacin; Electrochemical Techniques; Electrodes; Fluoroquinolones; Reference Standards; Regression Analysis; Rheology; Veterinary Drugs	2010
Plasma disposition and tissue depletion of difloxacin and its metabolite sarafloxacin in the food producing animals, chickens for fattening. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2011, Volume: 49, Issue:2 Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Area Under Curve; Bacteria; Chickens; Ciprofloxacin; Drug Residues; Drug Resistance; Half-Life; Injections, Intravenous; Microbial Sensitivity Tests; Molecular Structure	2011
Analysis of quinolone antibiotics in eggs: preparation and characterization of a raw material for method validation and quality control. Food chemistry, 2012, Oct-01, Volume: 134, Issue:3 Topics: Anti-Bacterial Agents; Chromatography, Liquid; Ciprofloxacin; Eggs; Enrofloxacin; Fluoroquinolones; Food Contamination; Norfloxacin; Oxolinic Acid; Quality Control; Quinolones; Reproducibility of Results	2012
A rapid and reliable assay to determine flumequine, marbofloxacin, difloxacin, and sarafloxacin in commonly consumed meat by micellar liquid chromatography. Journal of the science of food and agriculture, 2019, Volume: 99, Issue:3 Topics: Animals; Anti-Bacterial Agents; Cattle; Chromatography, Liquid; Ciprofloxacin; Drug Residues; Fluoroquinolones; Food Contamination; Goats; Horses; Meat; Poultry; Rabbits; Sheep; Swine	2019